-
US imposes new tariffs on 60 partners as Trump rebuilds trade agenda
-
Fear, arrests keep Cambodians quiet decade after critic's murder
-
Stocks suffer fresh blow as markets hit by perfect storm
-
Over 80% of Mexican exports exempt from new US tariffs
-
Trump under pressure from all sides over Chinese AI surge
-
Is 'superstar' Pogacar's Tour de France domination boring?
-
ICC member states decide fate of embattled prosecutor Karim Khan
-
Iran ramps up executions under shadow of war
-
Dodgers return to Trump White House despite fan anger
-
Rosalia's Argentine fans up in arms over alleged World Cup snub
-
Lyles, Richardson ease into 100m semis at US athletics championships
-
Six candidates to lead UN take stage for televised debate
-
Salman Rushdie testifies at knife attacker's US terror trial
-
King Charles opens slimmed down Commonwealth Games in Glasgow
-
World Bank confirms plan to phase out China lending by 2031
-
US unveils new tariffs on 60 partners as Trump rebuilds trade agenda
-
US panel backs trendy peptides despite safety concerns
-
WNBA viral star Cunningham wades into trans athletes row
-
Justice Dept withdraws NY Times subpoenas over Trump plane report
-
Hearn dismisses Fury talk of Joshua no-show for super fight
-
Barcelona's De Jong returns from World Cup with torn ligament
-
'Like a war zone': France evacuates 20,000 due to wildfires
-
Albania police teargas protesters against Trump-linked resort
-
Ships avoid Ukrainian grain ports after Russian attacks
-
US panel says to loosen restrictions on popular peptide despite safety concerns
-
Oil passes $100 a barrel again: why it's more serious this time
-
Verstappen swerves around future questions
-
Who are the six candidates vying to lead the UN?
-
EU renews online child sex abuse detection powers
-
Hamilton proud of recovery after hitting rock bottom a year ago
-
Airbus, Boeing fly in different directions at Farnborough
-
Carapaz eyes polkadot mountains jersey after stage win
-
Bab al-Mandeb Strait: another key oil shipping route under threat
-
Fields medal awarded to four young mathematicians
-
Deadly wildfires in Europe force thousands to flee
-
Carapaz claims Tour de France stage as Pogacar loses key team-mate
-
NATO to overhaul European fuel pipeline network
-
Alonso welcomes Aston Martin upgrade, warns against unreal expectations
-
US trade envoy to make tariff announcement as 10% duty soon expires
-
Anderson declares Man City 'kings of Manchester' after £116 mn move
-
Trump stuns Saudis by pinning nuclear deal to Israel ties
-
Relieved Russell says Mercedes have solved his power problems mystery
-
Tough day for Ubisoft stock topped with weaker revenues
-
Oil soars above $100 as Middle East fears grow
-
Swelling jet fuel costs hit American Airlines outlook
-
Venezuelans turn to scrap collecting in quake-hit beach 'paradise'
-
Carapaz climbs unopposed to Tour de France 18th stage win
-
Heptathlon champion Johnson-Thompson joins list of Commonwealth Games absentees
-
Sooryavanshi hits maiden 50 as India thump Zimbabwe in T20
-
Nigeria's Dangote raises $2.5bn to expand Africa's largest refinery
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
A.Ammann--VB